Champions Oncology (STU:2I3) EPS (Basic) : €0.45 (TTM As of Jan. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Champions Oncology EPS (Basic)?

Champions Oncology's basic earnings per share (Basic EPS) for the three months ended in Jan. 2025 was €0.32. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2025 was €0.45.

Champions Oncology's EPS (Diluted) for the three months ended in Jan. 2025 was €0.30. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 was €0.42.

Champions Oncology's EPS without NRI for the three months ended in Jan. 2025 was €0.35. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2025 was 0.47.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Champions Oncology EPS (Basic) Historical Data

The historical data trend for Champions Oncology's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Champions Oncology EPS (Basic) Chart

Champions Oncology Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

EPS (Basic)

Get a 7-Day Free Trial

-0.17

0.03

0.04

-0.36

-0.50

Champions Oncology Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EPS (Basic)	Get a 7-Day Free Trial															-0.17	-0.01	0.09	0.05	0.32

Champions Oncology EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Champions Oncology's Basic EPS for the fiscal year that ended in Apr. 2024 is calculated as

Basic EPS (A: Apr. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-6.781	-	0)	/	13.548
	=	-0.50

Champions Oncology's Basic EPS for the quarter that ended in Jan. 2025 is calculated as

Basic EPS (Q: Jan. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(4.342	-	0)	/	13.701
	=	0.32

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.45

Champions Oncology (STU:2I3) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Champions Oncology EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Champions Oncology's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Champions Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (STU:2I3) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

CSBR:USA 2I3:Germany

Address

One University Plaza, Suite 307, Hackensack, NJ, USA, 07601

Website

https://www.championsoncology.com

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Champions Oncology Headlines

No Headlines